Yy. Tyurina et al., PHENOXYL RADICALS OF ETOPOSIDE (VP-16) CAN DIRECTLY OXIDIZE INTRACELLULAR THIOLS - PROTECTIVE VERSUS DAMAGING EFFECTS OF PHENOLIC ANTIOXIDANTS, Toxicology and applied pharmacology, 131(2), 1995, pp. 277-288
Phenolic compounds can act as radical scavengers due to their ability
to donate a mobile hydrogen to peroxyl radicals produc ing a phenoxyl
radical if the phenoxyl radical formed in the radical scavenging react
ion efficiently interacts with vitally important biomolecules, then th
is interaction may result in cytotoxic effects rather than in antioxid
ant protection. In the present work we have chosen two model compounds
- a phenolic antitumor drug, VP-16, known to be highly cytotoxic, and
a homolog of vitamin E, 2,2,5,7,8-pentamethyl-6-hydroxychromane (PMC)
-as typical representatives of phenoxyl radicals to study interactions
of their phenoxyl radicals with intracellular thiols. Using a water-s
oluble source of peroxyl radicals, the azo-initiator 2,2'-azobis(2-ami
nodinopropane) (AAPH), we found that both PMC and VP-16 are very effic
ient scavengers of peroxyl radicals as evidenced by their ability to i
nhibit AAPH-induced chemiluminescence of luminol and oxidation of PnA
incorporated into DOPC liposomes. Both PMC and VP-16 were also able to
protect against AAPH-induced oxidative degradation of DNA in nuclei f
rom human leukemic K562 cells. In contrast, there was a dramatic diffe
rence in the ability of VP-16 and PMC to protect GSH against AAPH-indu
ced oxidation: while PMC inhibited AAPH-induced oxidation of GSH in a
concentration-dependent manner, VP-16 did not protect GSH against oxid
ation. We hypothesized that this was due to different reactivities of
the phenoxyl radicals formed by AAPH-derived peroxyl radicals from VP-
16 and PMC toward GSH. To substantiate this hypothesis, we compared in
teractions of the phenoxyl radicals generated from VP-16 and PMC with
intracellular thiols in K562 cell homogenates. While the PMC phenoxyl
radicals were only slightly affected by thiols, the VP-16 phenoxyl rad
icals were reduced by thiols. This is evidenced by (i) a significant i
nhibition of the tyrosinase-induced VP-16 consumption upon addition of
K562 cell homogenates, (ii) a depletion of endogenous thiols in K562
cell homogenates induced by VP-16+-tyrosinase, (iii) a transient disap
pearance of the VP-16 phenoxyl radical signal from the ESR spectra and
its reappearance after depletion of endogenous thiols, and (iv) elimi
nation of the lag period for the appearance of the VP-16 phenoxyl radi
cal ESR signal subsequent to depletion of thiols by mersalyl acid. To
evaluate the contribution of GSH and protein thiols to reduction of th
e VP-16 phenoxyl radical, we treated K562 cell homogenates with GSH-pe
roxidase + cumene hydroperoxide to specifically de plete endogenous GS
H. We found that GSH and protein thiols each account for about 50% of
the reduction of the VP-16 phe noxyl radical by K562 homogenates. Simi
larly, endogenous thiols in cell homogenates from several different cu
ltured cell lines were oxidized by VP-16 phenoxyl radicals (but not PM
C phenoxyl radicals). The results of this study suggest that the diffe
r ential effects of PMC and VP-16 in intracellular environments, antio
xidant protection or cytotoxicity, may be due, at least in part, to a
striking difference in the reactivity of their respective phenoxyl rad
icals toward endogenous thiols. In addition to their radical scavengin
g activity, the reactivity of phenoxyl radicals toward critical biomol
ecules should be carefully considered in the design and development of
biomedical antioxidants. (C) 1995 Academic Press, Inc.